Weight-loss drug linked to lower eye-disease risk in patients with diabetes
February 12, 2026
February 12, 2026
ITHACA, New York, Feb. 12 -- Cornell University posted the following news:
* * *
Weight-loss drug linked to lower eye-disease risk in patients with diabetes
*
The popular diabetes and weight-loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators. The findings may offer comfort to patients concerned about their eye . . .
* * *
Weight-loss drug linked to lower eye-disease risk in patients with diabetes
*
The popular diabetes and weight-loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators. The findings may offer comfort to patients concerned about their eye . . .